X-Linked adrenoleukodystrophy in children: Review of genetic, clinical, and MR imaging characteristics

American Journal of Roentgenology

Volumn 173, Issue 6, 1999, Pages 1575-1581

  Melhem, Elias R ^a   Barker, Peter B ^a   Raymond, Gerald V ^a   Moser, Hugo W ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LORENZO OIL;

ADRENAL INSUFFICIENCY; ADRENOLEUKODYSTROPHY; CHILD; CLINICAL FEATURE; DIAGNOSTIC IMAGING; GENETIC DISORDER; HUMAN; INCIDENCE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; X CHROMOSOME LINKED DISORDER;

EID: 0032717979     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.173.6.10584804     Document Type: Review

References (41)

1. Igarashi M, Schaumburg HH, Powers J, et al. Fatty acid abnormality in adrenoleukodystrophy. J Neurochem 1976;26:851-860
2. Singh I, Moser AB, Goldfischer S, et al. Lignoceric acid is oxidized in the peroxisomes: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy. Proc Natl Acad Sci USA 1984;81:4203-4207
3. Laxo O, Contreras M, Hashmi M, et al. Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy. Proc Natl Acad Sci USA 1988;85:7647-7651
4. Bezman L, Moser HW. The incidence of X-linked adrenoleukodystrophy and the relative frequency of its phenotypes. Am J Med Genet 1998;76:415-419
5. Moser HW. Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain 1997; 120:1485-1508
6. Smith KD, Kemp S, Braiterman LT, et al. X-linked adrenoleukodystrophy: genes, mutations, and phenotypes. Neurochem Res 1999;24:511-525
7. Singh I, Moser AB, Moser HW, et al. Adrenoleukodystrophy: impaired oxidation of VLCF in white blood cells, cultured skin fibroblasts and amniocytes. Pediatr Res 1984;18:286-290
8. Wanders RJA, vanRoermund CWT, Lageweg W, et al. X-linked adrenoleukodystrophy: biochemical diagnosis and enzyme defect. J Inherit Metab Dis 1992;15:634-644
9. Kumar AJ, Rosenbaum AE, Naidu S, et al. Adrenoleukodystrophy: correlating MR imaging with CT. Radiology 1987;165:496-504
10. Kumar AJ, Koehler W, Kruse B, et al. MR findings in adult-onset adrenoleukodystrophy. AJNR 1995;16:1227-1237
11. Loes DJ, Hite S, Moser HW, et al. Adrenoleukodystrophy: a scoring method for brain MR observation. AJNR 1994;15:1761-1766
12. Migeon BR, Moser HW, Moser AB, et al. Adrenoleukodystrophy: evidence for X-linkage, inactivation and selection favoring the mutant allele in heterozygous cells. Proc Natl Acad Sci USA 1981; 78:5066-5070
13. Mosser J, Douar A-M, Sarde C-O, et al. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 1993;361:726-730
14. Braiterman LT, Zheng S, Watkins PA, et al. Suppression of peroxisomal membrane protein defects by peroxisomal ATP binding cassette (ABC) proteins. Hum Mol Genet 1998;7:239-247
15. Kemp S, Wei H-M, Lu J-F, et al. Gene redundancy and pharmacological gene therapy: potential for X-linked adrenoleukodystrophy. Nature Med 1998;4:1261-1268
16. Schaumburg HH, Powers JM, Raine CS, et al. Adrenoleukodystrophy: a clinical and pathological study of 17 cases. Arch Neurol 1975;33:577-591
17. Powers J, Liu Y, Moser AB, et al. The inflammatory myelinopathy of adrenoleukodystrophy: cells, effector molecules, and pathogenetic implications. J Neuropathol Exp Neurol 1992;51:630-643
18. Moser HW, Moser AB, Smith KD, et al. Adrenoleukodystrophy: phenotypic variability: implications for therapy. J Inherit Metab Dis 1992;15:645-664
19. Van Geel BM, Assies J, Wanders RJA, et al. X-linked adrenoleukodystrophy: clinical presentation, diagnosis and therapy. J Neurol Neurosurg Psychiatr 1997;63:4-14
20. Rizzo WB. Lorenzo's oil: hope and disappointment. N Engl J Med 1993;329:801-802
21. Aubourg P, Adamsbaum C, Lavallard-Rousseau M-C, et al. A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy. N Engl J Med 1993;329:745-752
22. Krivit W, Lockman LA, Watkins PA, et al. The future for treatment by bone marrow transplantation for adrenoleukodystrophy, metachromatic leukodystrophy, globid cell leukodystrophy and Hurler syndrome. J Inherit Metab Dis 1995;18:398-412
23. Singh I, Khan M, Key L, et al. Lovastatin for X-linked adrenoleukodystrophy. N Engl J Med 1998; 339:702-703
24. Doerflinger N, Miclea JM, Lopez J, et al. Retroviral transfer and long-term expression of the adrenoleukodystrophy gene in human CD34+ cells. Hum Gene Therapy 1998;9:1025-1036
25. Powers JM. The pathology of peroxisomal disorders with pathogenetic considerations. J Neuropathol Exp Neurol 1994;54:710-719
26. Maravilla KR, Bowen BC. Imaging of the peripheral nervous system: evaluation of peripheral neuropathy and plexopathy. AJNR 1998;19:1011-1023
27. Wolff SD, Balaban RS. Magnetization-transfer imaging: practical aspects and clinical applications. Radiology 1994;192:593-599
28. Melnem ER, Breiter SN, Ulug AM, Raymond GV, Moser HW. Improved tissue characterization in adrenoleukodystrophy using magnetization transfer imaging. AJR 1996;166:689-695
29. Pierpaoli C, Jezzard P, Basser PJ, et al. Diffusion tensor MR imaging of the human brain. Radiology 1996;201:637-648
30. Neil JJ, Shiran SI, McKinstry RC, et al. Normal brain in human newboms: apparent diffusion coefficient and diffusion anisotropy measured by using diffusion tensor MR imaging. Radiology 1998;209:57-66
31. Tzika AA, Ball WS Jr, Vigneron DB, et al. Childhood adrenoleukodystrophy: assessment with proton MR spectroscopy. Radiology 1993;189:467-180
32. Kruse B, Barker PB, van Zijl PCM, et al. Multislice proton MR spectroscopic imaging in X-linked adrenoleukodystrophy. Ann Neurol 1994;36:595-608
33. Confort-Gouny S, Vion-Dury J, Chabrol B, et al. Localised proton magnetic resonance spectroscopy in X-linked adrenoleukodystrophy. Neuroradiology 1995;37:568-575
34. Rajanayagam V, Grad J, Krivit W, et al. Proton MR spectroscopy of childhood adrenoleukodystrophy. AJNR 1996;17:1013-1024
35. Tourbah A, Stievenart JL, Iba-Zizen MT, et al. Localized proton magnetic resonance spectroscopy in patients with adult adrenoleukodystrophy. Arch Neurol 1997;54:586-592
36. Pouwels PJW, Kruse B, Korenke GC, et al. Quantitative proton magnetic resonance spectroscopy of childhood adrenoleukodystrophy. Neuropediatrics 1998;29:254-265
37. Saeed N, Puri BK, Oatridge A, et al. Two methods for semi-automated quantification of changes in ventricular volume and their use in schizophrenia. Magn Reson Imaging 1998;16:1237-1247
38. Hewer G, Kenney C, Manjunath BS. Variational image segmentation using boundary functions. IEEE Trans Med imaging 1998;7:1269-1282
39. Reddick WE, Glass JO, Cook EN, et al. Automated segmentation and classification of multispectral magnetic resonance images of the brain using artificial neural networks. IEEE Trans Med Imaging 1997;16:911-918
40. vanBuchem MA, Udupa JK, McGowan JC, et al. Volumetric quantitation of intracranial macroscopic and microscopic disease burden based on magnetization transfer. AJNR 1997;18:1287-1290
41. Phillips MD, Grossman RI, Miki Y, et al. Comparison of T2 lesion volume and magnetization transfer ratio histogram analysis and of atrophy and measures of lesion burden in patients with multiple sclerosis. AJNR 1998;19:1055-1060